Charlotte Elisabeth Kahler LMT

Recommended Articles

• Separation Anxiety in Children: Symptoms, Causes, Diagnosis and More

  It’s normal for young children to feel anxious when they're separated from a loved one. However, when this fear occurs in a child above six years of age, is intense, and persists for more than four weeks, the child may have separation anxiety disorder.What is Separation Anxiety Disorder?Separation...

• FDA Approves Breakthrough Gene Therapy Treatment for Lymphoma

  Researchers have been working around the clock to find new and improved treatments for different cancers. Drugs, experiments, natural remedies, and more treatment options have been heavily explored in the search for a cure. Recently a new form of treatment has been developed by researchers that...

• Leading the Charge for Safe-Staffing: Alternative Method to Improve Nursing Care

  The American Nurse Association (ANA) Calls for Better Nurse-to-Patient Ratio In an economy slowly recovering from the recession back in 2008, nursing has been announced as one of the fastest growing jobs on the market. As a profession that will never die, more health care professionals are needed to...

• The Innovative Method to Detect Children’s Sleep Apnea

  Sleep apnea has, for the longest time, been one of the leading causes of sleep deprivation and complications with the sleep cycle of anyone who suffers from it. As said as much before, but this condition, which can equally affect persons of any gender, manifests itself as periods during sleep where...

• Does My Child Have Chicken Pox?

  The chicken pox virus is dangerous for pregnant women who were not vaccinated or did not undergo this infectious disease before pregnancy. The toxic part of the virus can lead to congenital (inborn) defects in a fetus and in severe cases, even to its death. The causing agent is a virus called...

• Nortis Inc. Receives $688K to Revolutionize Multiple Sclerosis Treatment

  One Seattle-based technology recently revealed new clinical technology that could completely change the way multiple sclerosis is treated. The firm received $668,000 to develop an in-vitro blood barrier that mimics the human blood-brain barrier, an innovation that would make MS drug development more...